Core Viewpoint - Xinhecheng (002001) focuses on two main sectors: nutrition and health, and high polymer new materials, emphasizing an integrated, series, and collaborative development strategy [1] Group 1: Business Strategy - The company aims to leverage its advantages in "technology + resources + market" to achieve a series, scale, and high value-added layout [1] - Xinhecheng is committed to extending the industrial chain around its existing business segments, fostering synergistic effects with its current industries [1] Group 2: Research and Development - All segments of the company are advancing research and development projects, indicating a rich reserve of projects [1]

Core Viewpoint - The company emphasizes the importance of talent as a source of innovation and aims to enhance its talent cultivation system and incentive mechanisms to boost employee engagement and corporate competitiveness [1] Group 1 - The company is currently implementing a share buyback program with a total amount ranging from 300 million to 600 million yuan, intended for equity incentive plans or employee stock ownership plans [1] - Future initiatives will focus on promoting equity incentives or employee stock ownership plans to align shareholder interests with corporate interests effectively [1] - The company aims to foster a collaborative environment where employees and the enterprise can create, share, and benefit together, thereby enhancing cohesion and competitiveness [1]

Core Viewpoint - The company is actively implementing its "Bio+" strategy by focusing on the development of biotechnological products, particularly in the field of fermentation products, which includes a diverse range of vitamins and amino acids [1] Group 1: Company Strategy - The Heilongjiang base is positioned for the production of bio-fermentation products [1] - The company has laid out a product line that includes Vitamin C, Coenzyme Q10, Vitamin B5, B12, as well as amino acids such as serine, cysteine, and tryptophan [1] - The company emphasizes technological innovation and management improvements to reduce costs and enhance efficiency [1] Group 2: Product Development - The company is committed to expanding its product offerings and improving product utilization through product line diversification and co-design [1] - There is a clear focus on developing new fermentation-based products, aiming to enrich the product matrix in this category [1] - The company is dedicated to building a "Bio+" platform that prioritizes technology in the development of new products [1]

Core Viewpoint - The company announced the construction of a nylon new material project in Tianjin South Port, which is set to enhance its competitiveness in the new materials sector [1] Group 1: Project Details - The nylon new material project focuses on the integrated production of "adiponitrile - hexamethylenediamine - nylon 66" across the entire industrial chain [1] - The project has officially commenced pile foundation construction as of September 2025 [1] Group 2: Strategic Considerations - The company considered factors such as integrated construction efficiency, cost, and logistics when selecting the project site [1] - The completion of this project is expected to further improve the company's layout in the new materials segment [1]

Core Insights - The company Xinhecheng (002001) announced on November 6 that over 50% of its products are exported to more than 100 countries and regions, highlighting its focus on overseas expansion and market development [1] Group 1: Overseas Expansion Strategy - The company emphasizes accelerating its international market presence as part of its 2025 operational guidance, stating "accelerate going abroad to expand the market" [1] - It has established overseas subsidiaries in regions such as Hong Kong, Singapore, Germany, Mexico, Brazil, Japan, and Vietnam [1] - The company has set up overseas research institutes in Singapore and Japan, indicating a commitment to both sales and research moving abroad [1] Group 2: Strategic Considerations for Overseas Operations - The selection of overseas factory locations will consider multiple factors, aligning with the company's development strategy and market dynamics [1]

Core Viewpoint - Xinhecheng (002001) is committed to providing safe, healthy, and nutritious products and solutions in the human nutrition sector, with a diverse range of products including vitamins and coenzymes [1] Product Offerings - The main products include Vitamin A, Vitamin D3, Vitamin E, Vitamin C, Coenzyme Q10, Taurine, Beta-Carotene, and Lycopene, showcasing a rich product variety [1] - The company offers customized formulations based on customer needs, indicating flexibility in product development [1] Market Application - Products are widely used in various fields such as health nutrition, baking, confectionery, and beverages, highlighting the versatility of the product applications [1] - The business has a global market presence, providing raw material supply to downstream customers [1]

Core Viewpoint - The company Xinhecheng (002001) is focusing on expanding its fragrance and flavor segment, which includes a variety of products widely used in personal care, household care, cosmetics, and food industries [1] Summary by Relevant Categories Business Operations - The fragrance and flavor segment primarily produces a range of products including linalool, citral, leaf alcohol, dihydro jasmine ketone methyl ester, raspberry ketone, ligustral, and menthol [1] - The company is currently maintaining a good profitability level in its fragrance and flavor business [1] Strategic Development - Xinhecheng is planning to develop a new fragrance industrial park in Shandong, covering approximately 1,000 acres, with projects currently in the early preparation and phased approval process [1] - The company aims to continuously optimize its product structure and enrich its fragrance product categories to enhance overall competitiveness [1]

（文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：尊敬的董秘，您好！贵公司在生物基材料有布局吗？ 主要布局的是哪几种产品？预计什么时候可以建成投产？产能大概有多少？市场前景如何？ 新和成（002001.SZ）11月6日在投资者互动平台表示，公司看好生物基材料，PPS产品已经推出了经过 ISCC认证的生物基规格，也会积极布局其他相关产品。 ...

Core Viewpoint - The company has successfully launched its liquid egg product in collaboration with Sinopec, marking a significant milestone in its third-quarter performance [2] Company Performance - The company reported strong results in its third-quarter earnings, indicating a positive trend in its financial performance [2] - The liquid egg product, specifically liquid egg methionine, has officially begun sales, which is expected to contribute to future revenue [2] Future Outlook - There is an inquiry regarding whether the performance of the liquid egg project will be reflected in concentrated dividends during the fourth quarter each year [2]

（文章来源：每日经济新闻） 新和成（002001.SZ）11月6日在投资者互动平台表示，分红是回馈投资者、共享公司发展成果的重要措 施。公司坚持以相对稳定的利润分配政策和现金分红方案积极回报股东，2025年公司实施了3次现金分 红，当年累计已派发现金分红达27.62亿元。后续分红方案敬请关注公司公告。 每经AI快讯，有投资者在投资者互动平台提问：请问董秘，贵公司是否计划了近几年的分红计划，如 果有，是多少？谢谢！ ...